-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Ngm Biopharmaceuticals Inc annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from 2017 to 2023.
- Ngm Biopharmaceuticals Inc Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$41.8M, a 17% decline year-over-year.
- Ngm Biopharmaceuticals Inc annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$132M, a 8.47% increase from 2022.
- Ngm Biopharmaceuticals Inc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$144M, a 97.2% decline from 2021.
- Ngm Biopharmaceuticals Inc annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$73.2M, a 12.3% increase from 2020.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)